The Latest Podcasts
Psychedelic Policy Briefing: Week of July 6, 2026
July 5, 2026
In this week’s Psychedelic Policy Briefing, Jack Gorsline breaks down the newly filed federal IBOGAINE Act, which would write key provisions of President Trump’s April executive order on psychedelic research into law. In Oregon, proposed licensing fee increases could push more of the state’s psilocybin service centers toward closure. In Washington, a New York Times investigation into Homeland Security Secretary Markwayne Mullin’s financial stake in a kratom company raises questions about the administration’s recent move against 7-hydroxymitragynine (7-OH). And at a House hearing on government secrecy, a former CIA officer testified about Project MKUltra, saying, “I don’t believe that the research stopped.”
Subscribe
Mike Finoia – The Comedy of Conscious Aging, Episode 16
Mike Finoia is a comedian based out of NYC. He is a writer/producer for TruTV’s Impractical…
Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture
Travis Tyler Fluck joins Joe Moore to discuss Denver mushroom decriminalization, the legacy of Initiative…
Filter
Martha Hammel and Tasia Poinsatte: Aspen Psychedelic Symposium
Aspen Psychedelic Symposium is the focus of this conversation with Martha Hammel of the Aspen…
Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy
Seeing What Is There is at the center of this conversation with journalist and author…
Dr. Michael Alpert and Peter Alberding: ALS, Existential Distress, and Ketamine Therapy
Dr. Michael Alpert and Peter Alberding discuss ALS, ketamine-assisted psychotherapy, end-of-life fear, music, trust, and…
Shane Mauss – Comedy and Molecules – Episode 14
Shane Mauss is an award-winning comedian (Conan, Kimmel, Comedy Central, Prime) with a fondness for…
Esme Dark: Psychedelics, Somatics and the Shadow
Dr. Esme Dark joins Kyle Buller for a conversation on psychedelic therapy, somatic psychotherapy, and…
Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics
Betty Aldworth and Ismail Ali, the co-executive directors of MAPS, join Psychedelics Today to discuss…